110 related articles for article (PubMed ID: 105356)
1. Gamma heavy chain disease in man: translation and partial purification of mRNA coding for the deleted protein.
Alexander A; Barritault D; Buxbaum J
Proc Natl Acad Sci U S A; 1978 Oct; 75(10):4774-8. PubMed ID: 105356
[TBL] [Abstract][Full Text] [Related]
2. Articular, monoclonal gamma3 heavy-chain deposition disease: characterization of a partially deleted heavy-chain gene and its protein product synthesized in vivo and in vitro.
Thompson KM; Sletten K; Brandtzaeg P; Källberg E; Wien TN; Husby G
Arthritis Rheum; 2003 Nov; 48(11):3266-71. PubMed ID: 14613292
[TBL] [Abstract][Full Text] [Related]
3. gamma Heavy chain disease in man: cDNA sequence supports partial gene deletion model.
Alexander A; Steinmetz M; Barritault D; Frangione B; Franklin EC; Hood L; Buxbaum JN
Proc Natl Acad Sci U S A; 1982 May; 79(10):3260-4. PubMed ID: 6808505
[TBL] [Abstract][Full Text] [Related]
4. Gamma heavy chain disease in man: synthesis of a deleted gamma3 immunoglobulin by lymphoid cells in short and long term tissue culture.
Buxbaum JN; Alexander A; Olivier O
Clin Exp Immunol; 1978 Jun; 32(3):489-97. PubMed ID: 80297
[TBL] [Abstract][Full Text] [Related]
5. Gamma heavy chain disease in man. Genomic sequence reveals two noncontiguous deletions in a single gene.
Alexander A; Anicito I; Buxbaum J
J Clin Invest; 1988 Oct; 82(4):1244-52. PubMed ID: 3139711
[TBL] [Abstract][Full Text] [Related]
6. A gamma l heavy-chain disease protein *EST) lacking the entire VH and CHl domains.
Biewenga J; Frangione B; Franklin EC; van Loghem E
Scand J Immunol; 1980; 11(6):601-7. PubMed ID: 6777865
[TBL] [Abstract][Full Text] [Related]
7. Multiple genomic defects result in an alternative RNA splice creating a human gamma H chain disease protein.
Guglielmi P; Bakhshi A; Cogne M; Seligmann M; Korsmeyer SJ
J Immunol; 1988 Sep; 141(5):1762-8. PubMed ID: 3137265
[TBL] [Abstract][Full Text] [Related]
8. Human heavy chain disease protein WIS: implications for the organization of immunoglobulin genes.
Franklin EC; Prelli F; Frangione B
Proc Natl Acad Sci U S A; 1979 Jan; 76(1):452-6. PubMed ID: 106391
[TBL] [Abstract][Full Text] [Related]
9. Gamma heavy chain disease in man: independent structural abnormalities and reduced transcription of a functionally rearranged lambda L-chain gene result in the absence of L-chains.
Teng MH; Rosen S; Gorny MK; Alexander A; Buxbaum J
Blood Cells Mol Dis; 2000 Jun; 26(3):177-85. PubMed ID: 10950937
[TBL] [Abstract][Full Text] [Related]
10. A pre-translational defect in a case of human mu heavy chain disease.
Bakhshi A; Guglielmi P; Coligan JE; Gamza F; Waldmann TA; Korsmeyer SJ
Mol Immunol; 1986 Jul; 23(7):725-32. PubMed ID: 3099178
[TBL] [Abstract][Full Text] [Related]
11. Mouse immunoglobulin genes: a bacterial plasmid containing the entire coding sequence for a pre-gamma 2a heavy chain.
Auffray C; Nageotte R; Chambraud B; Rougeon F
Nucleic Acids Res; 1980 Mar; 8(6):1231-41. PubMed ID: 6253932
[TBL] [Abstract][Full Text] [Related]
12. Gene mutations and alternate RNA splicing result in truncated Ig L chains in human gamma H chain disease.
Cogné M; Bakhshi A; Korsmeyer SJ; Guglielmi P
J Immunol; 1988 Sep; 141(5):1738-44. PubMed ID: 3137264
[TBL] [Abstract][Full Text] [Related]
13. Primary structure of human gamma 3 immunoglobulin deletion mutant: gamma 3 heavy-chain disease protein Wis.
Frangione B; Rosenwasser E; Prelli F; Franklin EC
Biochemistry; 1980 Sep; 19(18):4304-8. PubMed ID: 6774747
[TBL] [Abstract][Full Text] [Related]
14. Correlation of protein structure and immunoglobulin gene organization in the light of two new deleted heavy chain disease proteins.
Franklin EC; Kyle R; Seligmann M; Frangione B
Mol Immunol; 1979 Nov; 16(11):919-21. PubMed ID: 118919
[No Abstract] [Full Text] [Related]
15. Monoclonal IgM cryoglobulinemia associated with gamma-3 heavy chain disease: immunochemical and biochemical studies.
Wang AC; Arnaud P; Fudenberg HH; Creyssel R
Eur J Immunol; 1978 Jun; 8(6):375-9. PubMed ID: 97087
[TBL] [Abstract][Full Text] [Related]
16. Unusual genes at the aminoterminus of human immunoglobulin variants.
Frangione B; Franklin EC; Smithies O
Nature; 1978 Jun; 273(5661):400-1. PubMed ID: 96346
[No Abstract] [Full Text] [Related]
17. Genomic alterations in a case of alpha heavy chain disease leading to the generation of composite exons from the JH region.
Bentaboulet M; Mihaesco E; Gendron MC; Brouet JC; Tsapis A
Eur J Immunol; 1989 Nov; 19(11):2093-8. PubMed ID: 2513209
[TBL] [Abstract][Full Text] [Related]
18. The structural heterogeneity among degraded gamma heavy chain disease proteins.
Franklin EC
J Immunol; 1978 Dec; 121(6):2582-3. PubMed ID: 102697
[TBL] [Abstract][Full Text] [Related]
19. An unusual case of a plasma cell neoplasm with an IgG3lambda myeloma and a gamma3 heavy chain disease protein.
Adlersberg JB; Grann V; Zucker-Franklin D; Frangione B; Franklin EC
Blood; 1978 Jan; 51(1):85-96. PubMed ID: 412532
[TBL] [Abstract][Full Text] [Related]
20. Correlation between fragmented immunoglobulin genes and heavy chain deletion mutants.
Frangione B; Franklin EC
Nature; 1979 Oct; 281(5732):600-2. PubMed ID: 114864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
